Sign in

    ICU MEDICAL INC/DE (ICUI)

    Q1 2025 Earnings Summary

    Reported on May 8, 2025 (After Market Close)
    Pre-Earnings Price$142.87Last close (May 8, 2025)
    Post-Earnings Price$135.35Open (May 9, 2025)
    Price Change
    $-7.52(-5.26%)
    MetricYoY ChangeReason

    Total Revenue

    +6.7% (from $566.655M to $604.702M)

    The increase is attributed to sustained market demand and improved pricing strategies, driving revenue growth from $566.655M in Q1 2024 to $604.702M in Q1 2025.

    Operating Income

    Reversed from a loss of $10.655M to a profit of $12.888M

    The turnaround in operating income is driven by better operating efficiencies, cost control, and an improved product mix that helped transform a loss into profitability.

    Gross Profit

    +13.4% (from $185.244M to $210.109M)

    The gross profit improvement reflects enhanced production margins and effective cost management measures, increasing from $185.244M in Q1 2024 to $210.109M in Q1 2025.

    Net Loss

    Reduced by 60% (from $39.471M to $15.476M)

    The significant narrowing of the net loss is driven by operational leverage gains and margin improvements, decreasing the loss from $39.471M to $15.476M, indicating focused cost and efficiency measures.

    MetricPeriodGuidanceActualPerformance
    Revenue YoY
    Q1 2025
    Low- to mid-single-digit growth range
    6.7% YoY growth (from 566.655MTo 604.702M)
    Beat

    Research analysts covering ICU MEDICAL INC/DE.